Palisade Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.4M Sell
72,776
-846
-1% -$290K 2.43% 7
2026
Q1
$25.9M Sell
73,622
-324
-0.4% -$116K 2.6% 4
2025
Q4
$24.2M Sell
73,946
-895
-1% -$284K 2.36% 10
2025
Q3
$21.1M Buy
74,841
+750
+1% +$218K 1.96% 12
2025
Q2
$20.7M Buy
74,091
+600
+0.8% +$170K 2.06% 12
2025
Q1
$22.9M Buy
73,491
+281
+0.4% +$83K 2.35% 8
2024
Q4
$19.1M Buy
73,210
+1,262
+2% +$374K 1.94% 13
2024
Q3
$23.2M Sell
71,948
-334
-0.5% -$109K 2.27% 9
2024
Q2
$22.6M Sell
72,282
-3,886
-5% -$1.14M 2.34% 7
2024
Q1
$21.7M Sell
76,168
-209
-0.3% -$61.2K 2.11% 9
2023
Q4
$22M Buy
76,377
+82
+0.1% +$22.3K 2.41% 7
2023
Q3
$20.5M Buy
76,295
+110
+0.1% +$27.5K 2.49% 7
2023
Q2
$16.9M Buy
76,185
+1,719
+2% +$399K 1.96% 11
2023
Q1
$18M Sell
74,466
-57
-0.1% -$14K 2.21% 10
2022
Q4
$19.6M Sell
74,523
-574
-0.8% -$154K 2.24% 8
2022
Q3
$16.9M Sell
75,097
-108
-0.1% -$26.2K 2.32% 8
2022
Q2
$18.3M Sell
75,205
-10
-0% -$2.45K 2.35% 8
2022
Q1
$18.2M Buy
75,215
+510
+0.7% +$117K 2.09% 10
2021
Q4
$16.8M Buy
74,705
+1,027
+1% +$217K 1.88% 12
2021
Q3
$15.7M Buy
73,678
+4,567
+7% +$1.05M 1.91% 11
2021
Q2
$16.8M Buy
69,111
+328
+0.5% +$80.7K 1.98% 10
2021
Q1
$17.1M Sell
68,783
-515
-0.7% -$123K 2.2% 8
2020
Q4
$15.9M Buy
69,298
+1,045
+2% +$241K 2.17% 9
2020
Q3
$17.3M Sell
68,253
-891
-1% -$221K 2.61% 7
2020
Q2
$16.3M Sell
69,144
-589
-0.8% -$134K 2.6% 6
2020
Q1
$14.1M Buy
69,733
+110
+0.2% +$24K 2.58% 7
2019
Q4
$16.8M Buy
69,623
+130
+0.2% +$28.7K 2.46% 6
2019
Q3
$13.4M Buy
69,493
+546
+0.8% +$105K 2.05% 10
2019
Q2
$12.7M Sell
68,947
-1,320
-2% -$236K 1.97% 11
2019
Q1
$13.3M Sell
70,267
-22,502
-24% -$4.3M 2.11% 9
2018
Q4
$18.1M Buy
92,769
+1,204
+1% +$235K 2.65% 5
2018
Q3
$19M Sell
91,565
-76
-0.1% -$15K 2.51% 7
2018
Q2
$16.9M Buy
91,641
+2,913
+3% +$515K 2.44% 7
2018
Q1
$15.1M Buy
88,728
+4,274
+5% +$785K 2.29% 7
2017
Q4
$14.7M Buy
84,454
+1,355
+2% +$240K 2.32% 9
2017
Q3
$15.5M Buy
83,099
+2,515
+3% +$446K 2.82% 5
2017
Q2
$13.9M Buy
80,584
+6,096
+8% +$992K 2.72% 6
2017
Q1
$12.2M Buy
74,488
+2,625
+4% +$436K 2.24% 10
2016
Q4
$10.5M Sell
71,863
-6,040
-8% -$909K 2.01% 15
2016
Q3
$13M Buy
77,903
+42,665
+121% +$7.21M 2.42% 5
2016
Q2
$5.36M Buy
35,238
+825
+2% +$128K 1.01% 36
2016
Q1
$5.16M Buy
34,413
+2,715
+9% +$403K 1% 36
2015
Q4
$5.15M Sell
31,698
-2,385
-7% -$375K 1.1% 34
2015
Q3
$4.71M Sell
34,083
-50
-0.1% -$7.88K 1.05% 32
2015
Q2
$5.24M Sell
34,133
-105
-0.3% -$16.8K 1.04% 32
2015
Q1
$5.47M Buy
34,238
+2,705
+9% +$426K 1.08% 31
2014
Q4
$5.02M Sell
31,533
-675
-2% -$105K 0.99% 31
2014
Q3
$4.52M Buy
32,208
+509
+2% +$66.5K 0.93% 32
2014
Q2
$3.75M Buy
31,699
+1,720
+6% +$199K 0.79% 35
2014
Q1
$3.7M Buy
29,979
+700
+2% +$84.9K 0.81% 38
2013
Q4
$3.34M Sell
29,279
-433
-1% -$49.3K 0.76% 39
2013
Q3
$3.33M Sell
29,712
-5,306
-15% -$575K 0.85% 37
2013
Q2
$3.46M Buy
+35,018
New +$3.63M 0.87% 38

Other funds holding AMGN

Palisade Asset Management's AMGN Position: Q2 2026 in Review

Palisade Asset Management reduced its Amgen (AMGN) stake by 1.1% in Q2 2026, selling an estimated $290K and leaving 72,776 shares worth $26.4M. The position accounts for 2.43% of the portfolio, ranked #7.

Palisade Asset Management first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. 1,235 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Palisade Asset Management held 72,776 shares of Amgen worth $26.4M as of Q2 2026.
  • Palisade Asset Management sold 846 Amgen shares in Q2 2026, an estimated $290K.
  • Amgen made up 2.43% of Palisade Asset Management's portfolio in Q2 2026, its #7 holding.
  • Palisade Asset Management first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • 1,235 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Palisade Asset Management's 13F filing for Q2 2026, filed 20 Jul 2026.